Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine.

Saal, Lao LU orcid ; Vallon-Christersson, Johan LU orcid ; Häkkinen, Jari LU orcid ; Hegardt, Cecilia LU ; Grabau, Dorthe LU ; Winter, Christof LU ; Brueffer, Christian LU orcid ; Tang, Man-Hung Eric LU ; Reuterswärd, Christel LU and Schulz, Ralph LU , et al. (2015) In Genome Medicine 7(1).
Abstract
Breast cancer exhibits significant molecular, pathological, and clinical heterogeneity. Current clinicopathological evaluation is imperfect for predicting outcome, which results in overtreatment for many patients, and for others, leads to death from recurrent disease. Therefore, additional criteria are needed to better personalize care and maximize treatment effectiveness and survival.
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Genome Medicine
volume
7
issue
1
article number
20
publisher
BioMed Central (BMC)
external identifiers
  • pmid:25722745
  • wos:000350384900001
  • scopus:84924342071
  • pmid:25722745
ISSN
1756-994X
DOI
10.1186/s13073-015-0131-9
project
RNA sequencing for molecular diagnostics in breast cancer
Breast Cancer Surgery
Sweden Cancerome Analysis Network - Breast (SCAN-B): a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine
language
English
LU publication?
yes
id
1328145a-0809-4f77-84c5-16861222f134 (old id 5142571)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/25722745?dopt=Abstract
date added to LUP
2016-04-01 13:27:50
date last changed
2022-04-14 01:20:06
@article{1328145a-0809-4f77-84c5-16861222f134,
  abstract     = {{Breast cancer exhibits significant molecular, pathological, and clinical heterogeneity. Current clinicopathological evaluation is imperfect for predicting outcome, which results in overtreatment for many patients, and for others, leads to death from recurrent disease. Therefore, additional criteria are needed to better personalize care and maximize treatment effectiveness and survival.}},
  author       = {{Saal, Lao and Vallon-Christersson, Johan and Häkkinen, Jari and Hegardt, Cecilia and Grabau, Dorthe and Winter, Christof and Brueffer, Christian and Tang, Man-Hung Eric and Reuterswärd, Christel and Schulz, Ralph and Karlsson, Anna K and Ehinger, Anna and Malina, Janne and Manjer, Jonas and Malmberg, Martin and Larsson, Christer and Rydén, Lisa and Loman, Niklas and Borg, Åke}},
  issn         = {{1756-994X}},
  language     = {{eng}},
  number       = {{1}},
  publisher    = {{BioMed Central (BMC)}},
  series       = {{Genome Medicine}},
  title        = {{The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine.}},
  url          = {{https://lup.lub.lu.se/search/files/3387894/8057014}},
  doi          = {{10.1186/s13073-015-0131-9}},
  volume       = {{7}},
  year         = {{2015}},
}